Dexmedetomidine and Bupivacaine Intra-articular for Postoperative Analgesia After Knee Arthroscopic Surgery

Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18-65
SponsorAl-Azhar University

About this trial

The aim of this study to compare the analgesic effects of intraarticular dexmedetomidine added to bupivacaine with those of bupivacaine alone after knee arthroscopy

Eligibility criteria

Qualifiers

ASA I-II patients

Either sex

Aged 18-65 years

Candidates for anterior cruciate ligament (ACL) reconstruction by knee arthroscopy

Disqualifiers

the patients with kidney failure, liver failure, valvular and ischemic heart disease , high blood pressure, diabetes, history of infection and malignancy.

history of coagulation diseases, and history of drug allergies to used drugs.

those who consumed NSAIDs and analgesics 24 h before surgery were excluded from the study.

Trial design

Treatments tested in this trial

  • Normal Saline (Placebo)
  • Bupivacaine 0.25%
  • Dexmedetomidine

Treatment groups

75 Participants
are divided into 3 treatment groups

Sponsors and collaborators